Jefferies Group LLC Novartis Ag Call Options Transaction History

Jefferies Group LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2018 Feb 14, 2019	SELL	$73.66 - $82.02 $2.95 Million - $3.28 Million	-40,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $555,602 - $642,669	8,300 Added 26.18%	40,000 $3.45 Million
Q2 2018 Aug 14, 2018	BUY	$64.91 - $73.36 $1.23 Million - $1.39 Million	19,000 Added 149.61%	31,700 $2.4 Million
Q1 2018 May 15, 2018	BUY	$70.39 - $84.15 $893,953 - $1.07 Million	12,700 New	12,700 $1.03 Million

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.